Monitoring treatment response in ehrlichiosis is essential for ensuring dogs fully recover and to detect chronic disease or relapse.
Dogs not fully treated for ehrlichiosis can progress to debilitating chronic disease with bone marrow aplasia and profound immune dysfunction. Monitoring treatment response through repeat blood counts and PCR testing catches incomplete responses early and guides additional therapy before chronic disease develops.